226 related articles for article (PubMed ID: 34161094)
1. Discovery of Methylene Thioacetal-Incorporated α-RgIA Analogues as Potent and Stable Antagonists of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain.
Zheng N; Christensen SB; Dowell C; Purushottam L; Skalicky JJ; McIntosh JM; Chou DH
J Med Chem; 2021 Jul; 64(13):9513-9524. PubMed ID: 34161094
[TBL] [Abstract][Full Text] [Related]
2. Selective Penicillamine Substitution Enables Development of a Potent Analgesic Peptide that Acts through a Non-Opioid-Based Mechanism.
Gajewiak J; Christensen SB; Dowell C; Hararah F; Fisher F; Huynh PN; Olivera BM; McIntosh JM
J Med Chem; 2021 Jul; 64(13):9271-9278. PubMed ID: 34142837
[TBL] [Abstract][Full Text] [Related]
3. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
4. The α9α10 nicotinic acetylcholine receptors antagonist α-conotoxin RgIA reverses colitis signs in murine dextran sodium sulfate model.
AlSharari SD; Toma W; Mahmood HM; Michael McIntosh J; Imad Damaj M
Eur J Pharmacol; 2020 Sep; 883():173320. PubMed ID: 32645334
[TBL] [Abstract][Full Text] [Related]
5. Alpha-RgIA, a novel conotoxin that blocks the alpha9alpha10 nAChR: structure and identification of key receptor-binding residues.
Ellison M; Feng ZP; Park AJ; Zhang X; Olivera BM; McIntosh JM; Norton RS
J Mol Biol; 2008 Apr; 377(4):1216-27. PubMed ID: 18295795
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain.
Romero HK; Christensen SB; Di Cesare Mannelli L; Gajewiak J; Ramachandra R; Elmslie KS; Vetter DE; Ghelardini C; Iadonato SP; Mercado JL; Olivera BM; McIntosh JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1825-E1832. PubMed ID: 28223528
[TBL] [Abstract][Full Text] [Related]
7. Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice.
Callaghan B; Adams DJ
Channels (Austin); 2010; 4(1):51-4. PubMed ID: 20368690
[TBL] [Abstract][Full Text] [Related]
8. Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1.
Indurthi DC; Pera E; Kim HL; Chu C; McLeod MD; McIntosh JM; Absalom NL; Chebib M
Biochem Pharmacol; 2014 May; 89(1):131-40. PubMed ID: 24548457
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.
Azam L; McIntosh JM
J Neurochem; 2012 Sep; 122(6):1137-44. PubMed ID: 22774872
[TBL] [Abstract][Full Text] [Related]
10. Development of Conformationally Constrained α-RgIA Analogues as Stable Peptide Antagonists of Human α9α10 Nicotinic Acetylcholine Receptors.
Zheng N; Christensen SB; Blakely A; Dowell C; Purushottam L; McIntosh JM; Chou DH
J Med Chem; 2020 Aug; 63(15):8380-8387. PubMed ID: 32597184
[TBL] [Abstract][Full Text] [Related]
11. Interaction of rat α9α10 nicotinic acetylcholine receptor with α-conotoxin RgIA and Vc1.1: Insights from docking, molecular dynamics and binding free energy contributions.
Li R; Li X; Jiang J; Tian Y; Liu D; Zhangsun D; Fu Y; Wu Y; Luo S
J Mol Graph Model; 2019 Nov; 92():55-64. PubMed ID: 31330438
[TBL] [Abstract][Full Text] [Related]
12. d-Amino Acid Substitution of α-Conotoxin RgIA Identifies its Critical Residues and Improves the Enzymatic Stability.
Ren J; Zhu X; Xu P; Li R; Fu Y; Dong S; Zhangsun D; Wu Y; Luo S
Mar Drugs; 2019 Feb; 17(3):. PubMed ID: 30823399
[TBL] [Abstract][Full Text] [Related]
13. Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?
Mohammadi SA; Christie MJ
Toxins (Basel); 2015 Sep; 7(10):3916-32. PubMed ID: 26426047
[TBL] [Abstract][Full Text] [Related]
14. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
15. Substitution of D-Arginine at Position 11 of α-RgIA Potently Inhibits α7 Nicotinic Acetylcholine Receptor.
Wu Y; Zhang J; Ren J; Zhu X; Li R; Zhangsun D; Luo S
Mar Drugs; 2023 May; 21(6):. PubMed ID: 37367650
[TBL] [Abstract][Full Text] [Related]
16. Molecular Determinants Conferring the Stoichiometric-Dependent Activity of α-Conotoxins at the Human α9α10 Nicotinic Acetylcholine Receptor Subtype.
Yu R; Tae HS; Tabassum N; Shi J; Jiang T; Adams DJ
J Med Chem; 2018 May; 61(10):4628-4634. PubMed ID: 29733583
[TBL] [Abstract][Full Text] [Related]
17. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.
Chhabra S; Belgi A; Bartels P; van Lierop BJ; Robinson SD; Kompella SN; Hung A; Callaghan BP; Adams DJ; Robinson AJ; Norton RS
J Med Chem; 2014 Dec; 57(23):9933-44. PubMed ID: 25393758
[TBL] [Abstract][Full Text] [Related]
18. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
19. αS-conotoxin GVIIIB potently and selectively blocks α9α10 nicotinic acetylcholine receptors.
Christensen SB; Bandyopadhyay PK; Olivera BM; McIntosh JM
Biochem Pharmacol; 2015 Aug; 96(4):349-56. PubMed ID: 26074268
[TBL] [Abstract][Full Text] [Related]
20. Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor.
Halai R; Clark RJ; Nevin ST; Jensen JE; Adams DJ; Craik DJ
J Biol Chem; 2009 Jul; 284(30):20275-84. PubMed ID: 19447885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]